ARCHIVE SEARCH
      -OR-  
 
  NEWS CHANNELS
Fitness News
Asthma Allergy News
 > Diabetes News
Women's Health News
Men's Health News

  MY NEWS
Personal Archive
My Account

  ABOUT THIS NEWSFEED
About Us
Advertise With Us
Feed Your Site
Contact Us


Site Map
RSS News Feed 

  Website development & hosting
   by Cyber Software Solutions

 
Gene Variant Linked to Heart Disease in Type 2 Diabetes
Variant associated with glutamic acid metabolism

TUESDAY, Aug. 27 (HealthDay News) -- A variant of a gene associated with glutamic acid metabolism is linked to an increased risk of coronary heart disease in patients with type 2 diabetes, according to a study published in the Aug. 28 issue of the Journal of the American Medical Association.

Lu Qi, M.D., Ph.D., from the Harvard School of Public Health in Boston, and colleagues analyzed 2,543,016 common genetic variants from five independent sets of patients with type 2 diabetes, where 1,517 had coronary heart disease and 2,671 did not. The results were compared with patients without type 2 diabetes, where 737 had coronary heart disease and 1,637 did not.

The researchers found a significant association between variant rs10911021 present on chromosome 1q25 and the risk of coronary heart disease in patients with diabetes (risk allele frequency, 0.733 versus 0.679; odds ratio, 1.36). There was no association with this variant in patients without diabetes. Risk allele homozygotes had a significant, 32 percent decrease in expression of the glutamate-ammonia ligase gene and a significantly reduced ratio of pyroglutamic and glutamic acid. The metabolism of glutamine and glutamic acid has been shown to contribute to the regulation of insulin secretion and glucose metabolism, according to the authors.

"A single-nucleotide polymorphism (rs10911021) was identified that was significantly associated with coronary heart disease among persons with diabetes but not in those without diabetes and was functionally related to glutamic acid metabolism, suggesting a mechanistic link," Qi and colleagues conclude.

Several authors disclosed financial relationships with pharmaceutical companies.

Abstract
Full Text (subscription or payment may be required)



Copyright © 2013 HealthDay. All rights reserved.


Back to Top Stories
  GOOGLE ADS